Zhongliu Fangzhi Yanjiu

Magazine House of Cancer Research on Prevention and Treatment

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Zhongliu Fangzhi Yanjiu is an open-access journal published by Magazine House of Cancer Research on Prevention and Treatment in China, publishing in chinese. It is listed in DOAJ according to the sources read. Declared publication charge: 500 CNY. Declared review time at DOAJ: 36 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Magazine House of Cancer Research on Prevention and Treatment
ISSN
1000-8578
Country
China
Languages
chinese
Access
Open access
Declared publication charge
500 CNY
Articles in DOAJ
1613
Declared review time
36 weeks
Declared peer-review model
peer_review
Official website
https://www.zlfzyj.com/

Index listings

  • DOAJ · 2019-07-15
Indexing
DOAJ
APC
500 CNY
Declared review time (DOAJ)
36 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Dormant — no works recorded since 2019
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

1613

Most recent article

last month

Average review time (journal-declared via DOAJ)

36weeks

Works in OpenAlex

2937

Last recorded publication year

2021

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

5

i10-index

1

From OpenAlex open data (CC0).

Editorial & policy6
Last DOAJ review date
2026-07-30
Added to DOAJ
2019-07-15
Declared plagiarism screening
Declared
Other fees beyond APC
No
Editorial board
Official page ↗
Peer-review policy
View policy
Identity & continuity2
Alternate titles
Cancer Research on Prevention and Treatment
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Legal and Regulatory Analysis
  • Legal and Regulatory Analysis
  • Military Technology and Strategies
  • Linguistic, Cultural, and Literary Studies
  • Linguistic, Cultural, and Literary Studies
  • Military Technology and Strategies
  • Cancer Research and Treatments
  • Cancer Research and Treatments
Show all subjects (50)
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • Gastric Cancer Management and Outcomes
  • Gastric Cancer Management and Outcomes
  • RNA modifications and cancer
  • RNA modifications and cancer
  • Cancer Mechanisms and Therapy
  • Cancer Mechanisms and Therapy
  • Cancer-related gene regulation
  • Cancer-related gene regulation
  • Cancer-related Molecular Pathways
  • Cancer-related Molecular Pathways
  • Medical Research and Treatments
  • Medical Research and Treatments
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Head and Neck Cancer Studies
  • Medicinal Plant Pharmacodynamics Research
  • Medicinal Plant Pharmacodynamics Research
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Glycosylation and Glycoproteins Research
  • Glycosylation and Glycoproteins Research
  • Esophageal Cancer Research and Treatment
  • Esophageal Cancer Research and Treatment
  • Metastasis and carcinoma case studies
  • Metastasis and carcinoma case studies
  • Radiomics and Machine Learning in Medical Imaging
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer, Lipids, and Metabolism
  • Cancer, Lipids, and Metabolism
  • Lung Cancer Research Studies
  • Inflammatory mediators and NSAID effects
  • Monoclonal and Polyclonal Antibodies Research
  • Lung Cancer Research Studies
  • Inflammatory mediators and NSAID effects
  • Monoclonal and Polyclonal Antibodies Research

Keywords (DOAJ)

  • surgery
  • chemotherapy
  • radiotherapy
  • epidemiology
  • immunotherapy

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: